Differences in Structural Optical Coherence Tomography and Infrared Enface Images Between Non-exudative Macular Neovascularizations Secondary to AMD and Pachychoroid Disease

Overview

Journal Eye (Lond)

Specialty Ophthalmology

Date 2024 Sep 30

PMID 39349754

Authors

Emanuele Crincoli

Adriano Carnevali

Riccardo Sacconi

Fiammetta Catania

Francesco Bandello

Giuseppe Querques

Affiliations

Soon will be listed here.

Abstract

Purpose: To provide an analysis of structural optical coherence tomography (OCT) and enface infrared reflectance (IR) differences between non-exudative macular neovascularizations (NE MNVs) secondary to age-related macular degeneration (AMD) and NE MNVs secondary to pachychoroid spectrum.

Methods: Patients diagnosed with NE-MNV documented by OCTA and dye angiography in the context of either AMD or pachychoroid spectrum were retrospectively included in AMD group and PACHY group respectively. Only treatment-naïve NE MNVs showing persistence of non-exudative status for at least 1 year after diagnosis were considered. Availability of good quality structural OCT B scan and IR enface acquisitions both at baseline and at 1 year follow up was also required.

Results: The study population included 15 eyes of 15 patients in AMD group and 13 eyes of 13 patients in PACHY group. AMD group showed at baseline a significantly wider pigment epithelium detachment (PED) apex angle (p = 0.02), higher homogeneity of the PED (p = 0.015), higher PED shadowing(p = 0.03). Both groups experienced a widening of apex angle (flattening of the PED) during follow-up. Ten (76.9%) patients in PACHY group showed a hyporeflective halo at the margins of the PED at baseline compared to 3/15 (20.0%) patients in AMD group (0.007), with no significant changes at 1 year follow up (p = 0.47).

Conclusion: NE-MNVs in pachychoroid eyes are characterized by sharper and more inhomogeneous PEDs with a lighter choroidal shadowing compared to NE-MNVs in AMD eyes. Moreover, they often show a hyporeflective halo around the lesion with IR imaging.

References

Moult E, Alibhai A, Rebhun C, Lee B, Ploner S, Schottenhamml J . SPATIAL DISTRIBUTION OF CHORIOCAPILLARIS IMPAIRMENT IN EYES WITH CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION: A Quantitative OCT Angiography Study. Retina. 2019; 40(3):428-445. PMC: 7015807. DOI: 10.1097/IAE.0000000000002556. View

Kokame G, Liu K, Kokame K, Kaneko K, Omizo J . Clinical Characteristics of Polypoidal Choroidal Vasculopathy and Anti-Vascular Endothelial Growth Factor Treatment Response in Caucasians. Ophthalmologica. 2019; 243(3):178-186. DOI: 10.1159/000503834. View

Spaide R . The Ambiguity of Pachychoroid. Retina. 2020; 41(2):231-237. DOI: 10.1097/IAE.0000000000003057. View

Sacconi R, Tomasso L, Corbelli E, Carnevali A, Querques L, Casati S . Early response to the treatment of choroidal neovascularization complicating central serous chorioretinopathy: a OCT-angiography study. Eye (Lond). 2019; 33(11):1809-1817. PMC: 7002717. DOI: 10.1038/s41433-019-0511-2. View

Hara C, Wakabayashi T, Sayanagi K, Nishida K . Refractory Age-Related Macular Degeneration Due to Concurrent Central Serous Chorioretinopathy in Previously Well-Controlled Eyes. Pharmaceuticals (Basel). 2023; 16(1). PMC: 9864072. DOI: 10.3390/ph16010089. View

Matsumoto H, Hoshino J, Mukai R, Nakamura K, Kishi S, Akiyama H . Chronic choriocapillaris ischemia in dilated vortex vein region in pachychoroid neovasculopathy. Sci Rep. 2021; 11(1):16274. PMC: 8357816. DOI: 10.1038/s41598-021-95904-9. View

Narita C, Wu Z, Rosenfeld P, Yang J, Lyu C, Caruso E . Structural OCT Signs Suggestive of Subclinical Nonexudative Macular Neovascularization in Eyes with Large Drusen. Ophthalmology. 2020; 127(5):637-647. DOI: 10.1016/j.ophtha.2019.11.007. View

Forte R, Coscas F, Serra R, Cabral D, Colantuono D, Souied E . Long-term follow-up of quiescent choroidal neovascularisation associated with age-related macular degeneration or pachychoroid disease. Br J Ophthalmol. 2019; 104(8):1057-1063. DOI: 10.1136/bjophthalmol-2019-315189. View

Romdhane K, Zola M, Matet A, Daruich A, Elalouf M, Behar-Cohen F . Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy. Br J Ophthalmol. 2019; 104(7):910-916. DOI: 10.1136/bjophthalmol-2019-314625. View

10.

Carnevali A, Sacconi R, Querques L, Marchese A, Capuano V, Rabiolo A . Natural History of Treatment-Naïve Quiescent Choroidal Neovascularization in Age-Related Macular Degeneration Using OCT Angiography. Ophthalmol Retina. 2019; 2(9):922-930. DOI: 10.1016/j.oret.2018.02.002. View

11.

Carnevali A, Cicinelli M, Capuano V, Corvi F, Mazzaferro A, Querques L . Optical Coherence Tomography Angiography: A Useful Tool for Diagnosis of Treatment-Naïve Quiescent Choroidal Neovascularization. Am J Ophthalmol. 2016; 169:189-198. DOI: 10.1016/j.ajo.2016.06.042. View

12.

Sacconi R, Fragiotta S, Sarraf D, Sadda S, Freund K, Parravano M . Towards a better understanding of non-exudative choroidal and macular neovascularization. Prog Retin Eye Res. 2022; 92:101113. DOI: 10.1016/j.preteyeres.2022.101113. View

13.

Sacconi R, Sarraf D, Garrity S, Freund K, Yannuzzi L, Gal-Or O . Nascent Type 3 Neovascularization in Age-Related Macular Degeneration. Ophthalmol Retina. 2019; 2(11):1097-1106. DOI: 10.1016/j.oret.2018.04.016. View

14.

Dansingani K, Balaratnasingam C, Klufas M, Sarraf D, Freund K . Optical Coherence Tomography Angiography of Shallow Irregular Pigment Epithelial Detachments In Pachychoroid Spectrum Disease. Am J Ophthalmol. 2015; 160(6):1243-1254.e2. DOI: 10.1016/j.ajo.2015.08.028. View

15.

Gemmy Cheung C, Lai T, Teo K, Ruamviboonsuk P, Chen S, Kim J . Polypoidal Choroidal Vasculopathy: Consensus Nomenclature and Non-Indocyanine Green Angiograph Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup. Ophthalmology. 2020; 128(3):443-452. DOI: 10.1016/j.ophtha.2020.08.006. View

16.

Laiginhas R, Yang J, Rosenfeld P, Falcao M . Nonexudative Macular Neovascularization - A Systematic Review of Prevalence, Natural History, and Recent Insights from OCT Angiography. Ophthalmol Retina. 2020; 4(7):651-661. PMC: 7354220. DOI: 10.1016/j.oret.2020.02.016. View

17.

Querques G, Srour M, Massamba N, Georges A, Ben Moussa N, Rafaeli O . Functional characterization and multimodal imaging of treatment-naive "quiescent" choroidal neovascularization. Invest Ophthalmol Vis Sci. 2013; 54(10):6886-92. DOI: 10.1167/iovs.13-11665. View

18.

Shinojima A, Lee D, Tsubota K, Negishi K, Kurihara T . Retinal Diseases Regulated by Hypoxia-Basic and Clinical Perspectives: A Comprehensive Review. J Clin Med. 2021; 10(23). PMC: 8658588. DOI: 10.3390/jcm10235496. View

19.

Sakurada Y, Fragiotta S, Leong B, Parikh R, Hussnain S, Freund K . RELATIONSHIP BETWEEN CHOROIDAL VASCULAR HYPERPERMEABILITY, CHORIOCAPILLARIS FLOW DENSITY, AND CHOROIDAL THICKNESS IN EYES WITH PACHYCHOROID PIGMENT EPITHELIOPATHY. Retina. 2019; 40(4):657-662. DOI: 10.1097/IAE.0000000000002635. View

20.

Carnevali A, Capuano V, Sacconi R, Querques L, Marchese A, Rabiolo A . OCT Angiography of Treatment-Naïve Quiescent Choroidal Neovascularization in Pachychoroid Neovasculopathy. Ophthalmol Retina. 2019; 1(4):328-332. DOI: 10.1016/j.oret.2017.01.003. View